Earnings
Pfizer’s Post-Covid Portfolio Steps Into the Spotlight as Revenue Outlook Rises
Pfizer raised the low end of its full-year revenue outlook as non-Covid products offset a lower $4 billion Covid forecast.
Marcus Rivera • August 4, 2026
Earnings
Palantir Shares Jump 16% as 'Sovereign AI' Demand Drives Blowout Quarter
Palantir's 16% rally after Q2 results puts commercial AI demand and its 'sovereign AI' pitch in focus as Nasdaq reaches …
Sarah Chen • Aug 4
IPO
SpaceX Faces First Post-IPO Earnings Test as Analyst Sees Potential for 3x Stock Move
SpaceX’s first post-IPO earnings report could set its early valuation narrative as traders weigh a bullish analyst view …
James McAllister • Aug 4
Technology
IREN Completes Mirantis Acquisition as Bitcoin Miner Builds AI Cloud Software Stack
IREN’s Mirantis acquisition adds enterprise Kubernetes software to its AI cloud ambitions, potentially differentiating a…
Marcus Rivera • Aug 4
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Markets
Prologis-SEGRO Combination Puts $18.8 Billion Industrial REIT Deal in Focus
Sarah Chen • Aug 4, 2026
Markets
Dow Sets Record as Tech Rebound Pushes S&P 500 Within 0.3% of High
James McAllister • Aug 4, 2026
Technology
Lantheus’ $8 Billion Curium Merger Expands Radiopharmaceutical Reach Across 70 Countries
Marcus Rivera • Aug 3, 2026
Earnings
SUPN and INDV Jump as All-Stock Merger Creates Larger CNS Biopharma Company
Sarah Chen • Aug 3, 2026
Markets
KKR’s $5.7 Billion Integer Buyout Sets $127 Cash Target for ITGR Investors
James McAllister • Aug 3, 2026
